Literature DB >> 9541187

Expression of a vitamin D-regulated gene (VDUP-1) in untreated- and MNU-treated rat mammary tissue.

X Yang1, L H Young, J M Voigt.   

Abstract

Previous studies showed that the expression of an mRNA corresponding to VDUP-1 was decreased within MNU-induced rat mammary tumors. RNA from mammary tissue was DNase treated and reverse transcribed and the resulting cDNA was amplified using primers designed to amplify VDUP-1 (382 bp fragment) and glyceraldehyde-6-phosphate dehydrogenase (GAPDH) (416 bp fragment). Analysis of mammary cDNA derived from untreated or MNU-treated rats indicated that VDUP-1 expression within tumor tissue was significantly decreased, a finding which agrees with previous Northern blotting experiments. The differential expression was confirmed in tissue sections using an antisense VDUP-1 riboprobe for in situ hybridization studies which demonstrated that VDUP-1 staining in all cell types within tumor tissue was greatly decreased. VDUP-1 mRNA was expressed to a greater extent within epithelial cells and to a much lesser extent within stromal cells, including endothelial cells, in untreated mammary tissue. A significant decrease in VDUP-1 expression was detected as early as six weeks after MNU treatment, before tumors had formed. Bilateral ovariectomy did not alter VDUP-1 expression in untreated mammary tissue and ovariectomy prior to MNU treatment prevented tumor formation, as well as the associated decrease in VDUP-1 expression. The relative expression of VDUP-1 was higher in lung tissue than in adrenal, heart, kidney, liver, mammary, muscle, and ovary. Treatment of a cell line derived from an MNU-induced rat mammary tumor (MNU cells) with 1,25-dihydroxyvitamin D3 resulted in a significant increase in VDUP-1 expression and also inhibited cell growth in the absence of serum. The data are consistent with a role for VDUP-1 in mediating the inhibitory effects of 1,25-dihydroxyvitamin D3 on tumor cell growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541187     DOI: 10.1023/a:1005929714900

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.

Authors:  Vanisri Raviraj; Hui Zhang; Hsin-ya Chien; Louise Cole; Erik W Thompson; Lilian Soon
Journal:  Clin Exp Metastasis       Date:  2012-01-22       Impact factor: 5.150

2.  A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.

Authors:  Margaret E Tome; David B F Johnson; Lisa M Rimsza; Robin A Roberts; Thomas M Grogan; Thomas P Miller; Larry W Oberley; Margaret M Briehl
Journal:  Blood       Date:  2005-08-04       Impact factor: 22.113

Review 3.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

4.  Vitamin D3 up-regulated protein 1(VDUP1) is regulated by FOXO3A and miR-17-5p at the transcriptional and post-transcriptional levels, respectively, in senescent fibroblasts.

Authors:  De Xiang Zhuo; Xiao Hua Niu; Yi Cheng Chen; Dian Qi Xin; Ying Lu Guo; Ze Bin Mao
Journal:  J Biol Chem       Date:  2010-07-23       Impact factor: 5.157

Review 5.  Animal models of colorectal cancer.

Authors:  Robert L Johnson; James C Fleet
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

6.  Regulation of the bioavailability of thioredoxin in the lens by a specific thioredoxin-binding protein (TBP-2).

Authors:  Namal P M Liyanage; M Rohan Fernando; Marjorie F Lou
Journal:  Exp Eye Res       Date:  2007-05-21       Impact factor: 3.467

7.  Investigation of TXNIP (thioredoxin-interacting protein) and TRX (thioredoxin) genes for growth-related traits in pigs.

Authors:  Mei Yu; Becky Geiger; Nader Deeb; Max F Rothschild
Journal:  Mamm Genome       Date:  2007-04-04       Impact factor: 3.224

8.  TXNIP deficiency exacerbates endotoxic shock via the induction of excessive nitric oxide synthesis.

Authors:  Young-Jun Park; Sung-Jin Yoon; Hyun-Woo Suh; Dong Oh Kim; Jeong-Ran Park; Haiyoung Jung; Tae-Don Kim; Suk Ran Yoon; Jeong-Ki Min; Hee-Jun Na; Seon-Jin Lee; Hee Gu Lee; Young Ho Lee; Hee-Bong Lee; Inpyo Choi
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.